Director Declaration

Summary by AI BETAClose X

Schiehallion Fund Limited announced that Graeme Proudfoot, a non-executive director, has been appointed as a non-executive director of BioPharma Credit Plc, effective September 15, 2026. This disclosure is made in accordance with UK Listing Rule 6.4.9R(2).

Disclaimer*

Schiehallion Fund Limited (The)
15 September 2026
 

The Schiehallion Fund Limited

(the "Company")

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

 

UK Listing Rule 6.4.9R(2) Disclosure

The Schiehallion Fund Limited announces, in accordance with UKLR 6.4.9R(2,) that Graeme Proudfoot, a non-executive director of the Company, has been appointed as a non-executive director of BioPharma Credit Plc, with effect from 15  September 2026.

 

 

Altum (Guernsey) Limited

Company Secretary

15 September 2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings